181 related articles for article (PubMed ID: 37941546)
1. Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer.
Chen X; Yuan Q; Guan H; Shi X; Sun J; Wu Z; Ren J; Xia S; Shang D
Front Oncol; 2023; 13():1227606. PubMed ID: 37941546
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Characteristics and Therapeutic Implications of O-Glycan Synthesis in Pancreatic Cancer by Integrating Transcriptome and Single-Cell Data.
Huang B; Zhang B; Liu J; Wang T; Zhang Y; Zhang B; Yuan Q; Xia S; Shang D
Curr Med Chem; 2024 Apr; ():. PubMed ID: 38659264
[TBL] [Abstract][Full Text] [Related]
4. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer.
Zhang B; Huang B; Zhang X; Li S; Zhu J; Chen X; Song H; Shang D
Front Oncol; 2023; 13():1217654. PubMed ID: 37519797
[TBL] [Abstract][Full Text] [Related]
5. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes.
Cui Y; Yuan Q; Chen J; Jiang J; Guan H; Zhu R; Li N; Liu W; Wang C
Front Endocrinol (Lausanne); 2023; 14():1127441. PubMed ID: 37223030
[TBL] [Abstract][Full Text] [Related]
6. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract][Full Text] [Related]
8. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis Reveals Disulfidoptosis-Associated Genes as Promising Immunotherapeutic Targets: Insights Gained from Bulk Omics and Single-Cell Sequencing Validation.
Xu B; Li M; Weng N; Zhou C; Chen Y; Wei J; Fu L
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397869
[TBL] [Abstract][Full Text] [Related]
11. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
12. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
14. A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients.
Lan Y; Jia Q; Feng M; Zhao P; Zhu M
Front Genet; 2023; 14():1100020. PubMed ID: 37035749
[No Abstract] [Full Text] [Related]
15. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
Front Genet; 2022; 13():1053263. PubMed ID: 36712869
[No Abstract] [Full Text] [Related]
16. The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic Cancer.
Xie W; Li X; Yang C; Li J; Shen G; Chen H; Xiao SY; Li Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682857
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
[TBL] [Abstract][Full Text] [Related]
18. LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.
Li D; Zhang Q; Tang Y; Mao F; Zeng J; Ji A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11571-11584. PubMed ID: 37400573
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
Yin X; Kong L; Liu P
Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research.
Wei X; Ruan H; Zhang Y; Qin T; Zhang Y; Qin Y; Li W
Front Immunol; 2023; 14():1202150. PubMed ID: 37646041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]